-TheNewsMinute.com The scientists said that they have received partial funding and permission for implementing systematic surveillance of new variants of Coronavirus. Over 300 scientists from across India, including renowned names like Prof LS Shashidhara (Professor of Biology, IISER Pune and Ashoka University) and Prof Partha Majumder (National Science Chair, Government of India), have requested Prime Minister Narendra Modi to take steps to open access to various data in order to transparency in...

-The Hindu Leveraging existing schemes and providing universal social security is of utmost importance India is one of the largest welfare states in the world and yet, with COVID-19 striking in 2020, the state failed to provide for its most vulnerable citizens. The country witnessed multiple crises: mass inter- and intra-migration, food insecurity, and a crumbling health infrastructure. The extenuating circumstances of the pandemic has pushed an estimated 75 million people into...

-The Hindu Business Line Kerala’s handling of the Covid-19 pandemic has been the subject of international conversation about public health systems. Piloting Kerala’s fight against the pandemic is the State’s Health Minister and CPI(M)’s Central Committee member KK Shailaja who speaks exclusively to BusinessLine about the criticality of publicly-run healthcare and how the need of the hour is to nationalise the system. Excerpts: * What are the lessons to be learnt from...

-The Telegraph Centre’s revised policy has more than doubled the population of potential beneficiaries without immediate provisions for the extra doses needed India is likely to face extreme shortages of Covid-19 vaccines if all adults eligible for vaccination begin queuing up for the jabs from May 1, health and industry experts have said. The Centre’s revised vaccination policy has more than doubled the population of potential vaccine beneficiaries without immediate provisions for the...

-The Hindu Over the last few decades, intellectual property rules have served as a lethal barrier to the right to access healthcare Even an unprecedented pandemic can do little, it appears, to upset the existing global regime governing monopoly rights over the production and distribution of life-saving drugs. If anything, since the onset of COVID-19, we’ve only seen a reaffirmation of intellectual property rules that have served as a lethal barrier to...